Qureight has announced the appointment of Craig Rhodes as head of partnerships to lead strategic engagements with pharmaceutical organisations, in line with Qureight’s revenue growth targets.
As part of its strategic transformation into a CDMO (Contract Development and Manufacturing Organisation) for medical devices and complex pharmaceutical drug delivery systems, Sanner announces a management change.
Temperature-controlled packaging specialist Hydropac has announced the appointment of Kimon Konakoglou as head of research & development to support the company’s continued expansion of capabilities in the fast-growing pharmaceutical logistics sector.
OneChain Immunotherapeutics (OCI), a clinical-stage biotech company focused on the development of CAR-T therapies for the treatment of oncologic diseases, has announced the appointment of Barbara Krebs-Pohl as the new chair of the Board of Directors.
iOnctura, a clinical-stage biopharmaceutical company, has announced the appointments of Steven Sciuto as chief financial officer (CFO) and Michelle Tsai PharmD as chief operating officer (COO).
Concept Life Sciences has announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors.
Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery system, has announced the appointment of William J. Kullback to its board of directors as a non-executive director (NED).
